Search Results

ETC-1002 10mg 10mg  | Purity Not Available

Adooq Bioscience

ETC-1002 is a novel, first-in-class, orally available, once-daily LDL-C lowering small molecule; activator of hepatic AMP-activated protein kinase (AMPK); also has potent inhibitory activity against hepatic ATP-citrate lyase(IC50=29 uM).

More Information Supplier Page

EPI-001 50mg 50mg  | Purity Not Available

Adooq Bioscience

EPI-001 is an antagonist of the androgen receptor (AR) that acts by binding covalently to the N-terminal domain (NTD) of the AR and blocking protein-protein interactions required for transcriptional activity of the AR and its splice variants (IC50 for inhibition of AR NTD transactivation ?? 6 ?M)

More Information Supplier Page

EPI-001 25mg 25mg  | Purity Not Available

Adooq Bioscience

EPI-001 is an antagonist of the androgen receptor (AR) that acts by binding covalently to the N-terminal domain (NTD) of the AR and blocking protein-protein interactions required for transcriptional activity of the AR and its splice variants (IC50 for inhibition of AR NTD transactivation ?? 6 ?M)

More Information Supplier Page

EPI-001 10mg 10mg  | Purity Not Available

Adooq Bioscience

EPI-001 is an antagonist of the androgen receptor (AR) that acts by binding covalently to the N-terminal domain (NTD) of the AR and blocking protein-protein interactions required for transcriptional activity of the AR and its splice variants (IC50 for inhibition of AR NTD transactivation ?? 6 ?M)

More Information Supplier Page

GSK2141795 5mg 5mg  | Purity Not Available

Adooq Bioscience

Akt inhibitor GSK2141795 binds to and inhibits the activity of Akt, which may result in inhibition of the PI3K/Akt signaling pathway and tumor cell proliferation and the induction of tumor cell apoptosis.

More Information Supplier Page

ETC-1002 5mg 5mg  | Purity Not Available

Adooq Bioscience

ETC-1002 is a novel, first-in-class, orally available, once-daily LDL-C lowering small molecule; activator of hepatic AMP-activated protein kinase (AMPK); also has potent inhibitory activity against hepatic ATP-citrate lyase(IC50=29 uM).

More Information Supplier Page